Kymera Therapeutics, Inc. · NASDAQ:KYMR

Mainolfi Nello sold 80,000 Kymera Therapeutics, Inc. shares (Form 4)

Traded Jul 1, 2026 · Filed Jul 2, 2026

On Jul 1, 2026, Mainolfi Nello (Director, Chief Executive Officer) sold 80,000 Kymera Therapeutics, Inc. shares at an average US$115.30 for US$9.22M under a trading plan, leaving 666,568 shares. Filed Jul 2, 2026 (Form 4).

Sold
80,000 shares
Price
US$115.30 average (US$112.80 to US$116.56)
Value
US$9.22M
Holding after
666,568 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 1, 2026Common StockOption exercise80,000US$2.08746,568Direct
Jul 1, 2026Common StockSale1,883US$112.80744,685Direct
Jul 1, 2026Common StockSale6,626US$113.98738,059Direct
Jul 1, 2026Common StockSale24,105US$114.96713,954Direct
Jul 1, 2026Common StockSale44,050US$115.69669,904Direct
Jul 1, 2026Common StockSale3,336US$116.56666,568Direct

Source

View original at SEC

Related